Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL353101

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCOC(=O)C1=CC2C(=O)c3ncccc3C(=O)C2C(c2ccc([N+](=O)[O-])cc2)=N1
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL353101
Phase Preclinical
Structure Type MOL
InChI Key OPUCKZXLLQAVDR-UHFFFAOYSA-N
10
Targets
13
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names

Molecular Properties

405.4
MW (Da)
2.55
ALogP
8
HBA
0
HBD
128.8
PSA (Ų)
0.43
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C21H15N3O6
MW 405.37
Aromatic Rings 2
Heavy Atoms 30
NP-Likeness -0.42

Activity Summary

IC50 13 meas. best 9.0

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
MT4
CHEMBL388
 IC50 9.0 9.0 1.0 1
WIL2-NS
CHEMBL612810
 IC50 9.0 9.0 1.0 1
SK-MEL-28
CHEMBL614919
 IC50 9.0 9.0 1.0 1
CCRF-SB
CHEMBL614542
 IC50 8.7 8.7 2.0 1
DU-145
CHEMBL613508
 IC50 8.0 8.0 10.0 1
SK-MES-1
CHEMBL614923
 IC50 8.0 8.0 10.0 1
CCRF-CEM
CHEMBL382
 IC50 7.3 7.3 50.0 1
HepG2
CHEMBL395
 IC50 7.16 7.16 70.0 1
MCF7
CHEMBL387
 IC50 7.1 7.1 80.0 1
KB
CHEMBL398
 IC50 7.1 6.68 80.0 4

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
WIL2-NS IC50 = 1.0 nM 9.0 Concentration required to reduce proliferation of human splenic B-lymphoblastoid... 14761187
MT4 IC50 = 1.0 nM 9.0 Concentration required to reduce proliferation of CD4+ human acute T-lymphoblast... 14761187
SK-MEL-28 IC50 = 1.0 nM 9.0 Concentration required to reduce proliferation of human breast adenocarcinoma (S... 14761187
CCRF-SB IC50 = 2.0 nM 8.7 Concentration required to reduce proliferation of human acute B-lymphoblastic (C... 14761187
SK-MES-1 IC50 = 10.0 nM 8.0 Concentration required to reduce proliferation of human lung squamous carcinoma ... 14761187
DU-145 IC50 = 10.0 nM 8.0 Concentration required to reduce proliferation of human prostate carcinoma (DU-1... 14761187
CCRF-CEM IC50 = 50.0 nM 7.3 Concentration required to reduce proliferation of CD4+ human acuteT-lymphoblasti... 14761187
HepG2 IC50 = 70.0 nM 7.16 Concentration required to reduce proliferation of human hepatocellular carcinoma... 14761187
MCF7 IC50 = 80.0 nM 7.1 Concentration required to reduce proliferation of human breast adenocarcinoma (M... 14761187
KB IC50 = 80.0 nM 7.1 Concentration required to reduce proliferation of KB human nasopharyngeal carcin... 14761187
KB IC50 = 200.0 nM 6.7 Concentration required to reduce proliferation of KB subclones passaged in the p... 14761187
KB IC50 = 300.0 nM 6.52 Concentration required to reduce proliferation of KB subclones passaged in the p... 14761187
KB IC50 = 400.0 nM 6.4 Concentration required to reduce proliferation of KB subclones passaged in the p... 14761187

Literature References

PubMed DOI Target Context # Activities
14761187 10.1021/jm030918b KB 4
14761187 10.1021/jm030918b WIL2-NS 1
14761187 10.1021/jm030918b CCRF-CEM 1
14761187 10.1021/jm030918b CCRF-SB 1
14761187 10.1021/jm030918b MT4 1
14761187 10.1021/jm030918b SK-MEL-28 1
14761187 10.1021/jm030918b MCF7 1
14761187 10.1021/jm030918b SK-MES-1 1
14761187 10.1021/jm030918b HepG2 1
14761187 10.1021/jm030918b DU-145 1
14761187 10.1021/jm030918b CRL-7065 cell line 1

Data from ChEMBL 36 via Core Engine